|
|
|
|
LEADER |
02033nam a22003615i 4500 |
001 |
000282766 |
005 |
20210806104031.0 |
007 |
cr nn 008mamaa |
008 |
141128s2015 gw | s |||| 0|eng d |
020 |
|
|
|a 9783319115146
|
024 |
7 |
|
|a 10.1007/978-3-319-11514-6
|2 doi
|
040 |
|
|
|a Sistema de Bibliotecas del Tecnológico de Costa Rica
|
245 |
1 |
0 |
|a Drug Treatment of Sleep Disorders /
|c edited by Antonio Guglietta.
|
250 |
|
|
|a 1st ed. 2015.
|
260 |
# |
# |
|a Cham :
|b Springer International Publishing :
|b Imprint: Springer,
|c 2015.
|
300 |
|
|
|a VIII, 297 p. 23 illus., 14 illus. in color. :
|b online resource.
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
490 |
1 |
|
|a Milestones in Drug Therapy,
|
505 |
0 |
|
|a An overview of sleep physiology and sleep regulation -- Neuronal networks regulating sleep and arousal: effect of drugs -- Classification of sleep disorders -- Development of new therapeutical agents for treatment of insomnia and other sleep disorders -- Low dose doxepin for insomnia -- Lorediplon: a new GABAa modulator drug for treatment of insomnia -- Zolpidem sublingual formulations -- Eszopiclone: review and clinical applications in chronic and co-morbid insomnia -- Orexin/hypocretin antagonists in insomnia: from bench to clinic -- Modafinil and armodafinil -- Sodium oxybate (Xyrem®): a new and effective treatment for narcolepsy with cataplexy -- Cell therapy to treat narcolepsy -- Tasimelteon -- The past, present and future of drug development and treatment in sleep disorders.
|
650 |
|
0 |
|a Pharmacology.
|
650 |
|
0 |
|a Neurosciences.
|
650 |
|
0 |
|a Pharmacotherapy.
|
650 |
|
0 |
|a Psychopharmacology.
|
650 |
1 |
4 |
|a Pharmacology/Toxicology.
|
650 |
2 |
4 |
|a Neurosciences.
|
650 |
2 |
4 |
|a Pharmacotherapy.
|
650 |
2 |
4 |
|a Psychopharmacology.
|
700 |
1 |
|
|a Guglietta, Antonio.
|e editor.
|
710 |
2 |
|
|a SpringerLink (Online service)
|
773 |
0 |
|
|t Springer eBooks
|
900 |
|
|
|a Libro descargado a ALEPH en bloque (proveniente de proveedor)
|